Raising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension

dc.contributor.authorAkay, Tankut
dc.contributor.authorKaymaz, Cihangir
dc.contributor.authorAkar, Ahmet Ruchan
dc.contributor.authorOrhan, Gokcen
dc.contributor.authorYanartas, Mehmed
dc.contributor.authorGultekin, Bahadir
dc.contributor.authorSirlak, Mustafa
dc.contributor.authorKervan, Umit
dc.contributor.authorTas, Serpil Gezer
dc.contributor.authorBicer, Murat
dc.contributor.authorYagdi, Tahir
dc.contributor.authorIspir, Selim
dc.contributor.authorDogan, Riza
dc.date.accessioned2023-02-21T12:40:55Z
dc.date.available2023-02-21T12:40:55Z
dc.date.issued2021-01-01
dc.description.abstractChronic thromboembolic pulmonary hypertension is an underdiagnosed and potentially fatal subgroup of pulmonary hypertension, if left untreated. Clinical signs include exertional dyspnea and non-specific symptoms. Diagnosis requires multimodality imaging and heart catheterization. Pulmonary endarterectomy, an open heart surgery, is the gold standard treatment of choice in selected patients in specialized centers. Targeted medical therapy and balloon pulmonary angioplasty can be effective in high-risk patients with significant comorbidities, distal pulmonary vascular obstructions, or recurrent/persistent pulmonary hypertension after pulmonary endarterectomy. Currently, there is a limited number of data regarding novel coronavirus-2019 infection in patients with chronic thromboembolic pulmonary hypertension and the changing spectrum of the disease during the pandemic. Challenging times during this outbreak due to healthcare crisis and relatively higher case-fatality rates require convergence
dc.description.abstractthat is an ultradisciplinary collaboration, which crosses disciplinary and sectorial boundaries to develop integrated knowledge and new paradigms. Management strategies for the ``new normal{''} such as virtual care, preparedness for further threats, redesigned standards and working conditions, reevaluation of specific recommendations, and online collaborations for optimal decisions for chronic thromboembolic pulmonary hypertension patients may change the poor outcomes.
dc.description.issue3
dc.description.issueJUL
dc.description.pages417-431
dc.description.volume29
dc.identifier.doi10.5606/tgkdc.dergisi.2021.21284
dc.identifier.urihttps://hdl.handle.net/11443/2665
dc.identifier.urihttp://dx.doi.org/10.5606/tgkdc.dergisi.2021.21284
dc.identifier.wosWOS:000678527700020
dc.publisherBAYCINAR MEDICAL PUBL-BAYCINAR TIBBI YAYINCILIK
dc.relation.ispartofTURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
dc.subjectBalloon pulmonary angioplasty
dc.subjectchronic thromboembolic pulmonary hypertension
dc.subjectpulmonary endarterectomy
dc.subjectpulmonary thromboembolism
dc.subjecttargeted medical therapy
dc.titleRaising the bar to ultradisciplinary collaborations in management of chronic thromboembolic pulmonary hypertension
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Raising the bar to ultradisciplinary collaborations in management of.pdf
Size:
1.36 MB
Format:
Adobe Portable Document Format

Collections